NuOrtho's surgical probe cleared by FDA
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for NuOrtho Surgical's Ceruleau, an electrosurgical probe designed to remove damaged cartilage tissue. The device is intended for use during knee or shoulder surgery. It reduces damage to healthy cartilage, NuOrtho claims, because it operates at lower temperatures and energy levels than similar devices. This is the first approval for the firm, which is based at the Advanced Technology and Manufacturing Center of the University of Massachusetts, Dartmouth. The centre helps support start-up companies, and aims to promote partnerships between the university and industry.